Navigation Links
Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
Date:12/6/2007

ing to see the recognition for our innovation which is expected to bring significant contributions to patients afflicted with dermatology diseases and the physicians who treat them."

"Electrokinetic drug delivery has emerged as an alternative approach to overcome the limitations of, and to obviate the need for, hypodermic injection of many medications," said Pramodh Ishwarakrishnan, Frost & Sullivan Industry Analyst. "Transport Pharmaceuticals has achieved the noble distinction of creating a system which is poised to revolutionize the field of dermal drug delivery."

The Challenges and Promise of Transdermal Delivery

The outer layer of the skin, known as the stratum corneum, is a highly effective, impermeable barrier that serves as the immune system's natural first-line of defense. The stratum corneum prevents xenobiotics, external molecules or microorganisms from entering the body. It is this same barrier function that prevents topically applied drugs from reaching their target tissue in efficacious quantities.

The promise of Transport's technology lies in its ability to deliver a safe and effective therapeutic depot, directly in the affected tissue. The key advantages of this are two-fold; a high dose of potent drug rapidly and painlessly reaches the affected dermal tissue, while the patient avoids the potential toxicity and adverse effects associated with systemic exposure to a drug intended to act only on the skin. Transport's technology enhances both the delivery of topically applied drugs and the utility of potent, systemically delivered drugs, whose uses are limited by bioavailability, toxicity or side-effect concerns. While Transport's initial focus is herpes labialis, future indications include, onychomycosis, acne, actinic keratosis, keloids, warts, psoriasis, skin cancer and medical aesthetic applications.

About Best Practices

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and g
'/>"/>

SOURCE Transport Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
2. Bioscrypts V-Station MIFARE Placed on Transportation Security Administrations Qualified Products List
3. Mechanism for the in-vivo transport of siRNA
4. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
5. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. ... a leading developer, manufacturer, and distributor of crop nutrient ... , today announced that, on May 16, 2013, ... of directors (the "Board of Directors") was provided a ... Hong Kong ) Limited ("Abax") to Full ...
(Date:5/17/2013)... May 17, 2013 RURO Inc. ... version 4.1, a versatile refinement to the smart ... solution, improves its advanced methodical management for transgenic ... ezColony 4.1. The network-based platform provides user access ... research. While continuing to emphasize streamlined tasks, such ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... Barbara A. Myers, CAE, to the newly created ... her new role, Myers will be responsible for ... and production strategies, advancing the Society’s Member-led and ... and continuing to refine organizational, membership and product ...
(Date:5/16/2013)... 16, 2013 Kitware , ... today announces new Phase II SBIR funding from ... development of an open-source, high performance computing (HPC) ... framework enables researchers to select only the toolkits ... simulation, computation, or analysis tasks. , Manufacturers ...
Breaking Biology Technology:Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2
... rise 3% over Fiscal 2006 to $27.5 million - ... Canadian dollars unless otherwise noted), BELLEVILLE, ON, Sept. ... research-based, technology-driven Canadian,biopharmaceutical company, today announced financial results for ... recent announcements of the first shipment and commercial usage ...
... Nastech,Pharmaceutical Company Inc. (Nasdaq: NSTK ) will be ... City on Thursday, October 4, 2007,from 12:00 p.m. - ... at Times,Square, on 270 West 43rd Street. The luncheon ... Ph.D., Chairman, President and,Chief Executive Officer and Gordon Brandt, ...
... is pleased to announce that the majority shares in ... Tampa,FL. (http://www.healthedgepartners.com ). Paul Guilbaud, ABT President ... exciting development of ABT. The acquisition allows us to ... necessary infrastructure for our,world- wide sales expansion and allow ...
Cached Biology Technology:Bioniche Reports Fiscal 2007 Year-End Results 2Bioniche Reports Fiscal 2007 Year-End Results 3Bioniche Reports Fiscal 2007 Year-End Results 4Bioniche Reports Fiscal 2007 Year-End Results 5Bioniche Reports Fiscal 2007 Year-End Results 6Bioniche Reports Fiscal 2007 Year-End Results 7Bioniche Reports Fiscal 2007 Year-End Results 8Bioniche Reports Fiscal 2007 Year-End Results 9Bioniche Reports Fiscal 2007 Year-End Results 10Nastech to Host 2007 Analyst and Institutional Investor Day 2Nastech to Host 2007 Analyst and Institutional Investor Day 3Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL 2
(Date:5/17/2013)... The iCargo project (Intelligent Cargo in Efficient and Sustainable ... thanks to an improvement in the efficiency of intermodal ... assist decision making. It comprises 29 European organisations with ... management. It has a budget totalling 17,000,000 and a ... is working to specify and develop the semantic components ...
(Date:5/17/2013)... of American Societies for Experimental Biology (FASEB) released a ... (NIH) funding trends highlighting the devastating impact of sequestration ... FASEB analysis follows a May 15th Senate Appropriations Committee ... testified that the $1.6 billion cut the agency sustained ... substantial impact on the scientific community." , According ...
(Date:5/16/2013)... a commitment to the support of underrepresented minority ... Foundation has announced the inaugural AGA Investing in ... by the National Institute of Diabetes and Digestive ... underrepresented minority students to further their research careers ... establishing this new award, AGA demonstrates its commitment ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... of years, Inupiat Eskimos have relied on the bounty of ... shoreline. Professor Deborah Bronk of the Virginia Institute of ... Arctic coastal ecosystem, and how climate change might affect the ... native peoples depend. Bronk,s research team, which will travel ...
... RIVERSIDE, Calif. Geologists at the University of California, ... indicates that Earth,s ancient oceans were oxygen-free and, surprisingly, ... are the first to show that ample hydrogen sulfide ... history," said Timothy Lyons , a professor of ...
... a vital process for oxygen-breathing organisms. Understanding how small ... is also important in catalysis or the implementation of ... porphyrin rings with a central cobalt or iron atom. ... these substances. An important characteristic of porphyrins is ...
Cached Biology News:Researchers brave icy waters to study Arctic food web 2Researchers brave icy waters to study Arctic food web 3Oxygen-free early oceans likely delayed rise of life on planet 2Oxygen-free early oceans likely delayed rise of life on planet 3Direct observation of carbon monoxide binding to metal-porphyrines 2
... is a fully automated microplate luminescence ... widest possible range of applications based ... assays luciferase, -galactosidase, gene activities with ... Luminescent Immunoassays Cell-based assays ...
... dispensers save space and organize gloves, ... garb. They are the perfect benchtop ... in labs, processing and manufacturing. Clear ... the particles they attract. Open-slot design ...
... handy dispensers save space and organize ... other garb. They are the perfect ... used in labs, processing and manufacturing. ... and the particles they attract. Many ...
... to the D-2000, except that it uses a ... wavelength range and comes with a shutter (controlled ... D-2000 Deuterium Light Source produces a powerful, ... versions of the light source are available, providing ...
Biology Products: